Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 23 (2) , 155-168
- https://doi.org/10.1097/00004714-200304000-00008
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are widely used as effective pharmacological agents to treat depressive disorders. In contrast to the SSRIs, which block the presynaptic serotonin (5-HT) transporter and by this route increase the concentration of serotonin in the synaptic cleft, the antidepressant tianeptine enhances the presynaptic neuronal reuptake of 5-HT and thus decreases serotonergic neurotransmission. Both SSRIs and tianeptine are clinically effective; however, their opposite modes of action challenge the prevailing concepts on the need of enhancement of serotonergic neurotransmission. To better understand the differences between these two opposite pharmacological modes of action, we compared the changes induced by tianeptine and paroxetine on psychopathology, the hypothalamic-pituitary-adrenocortical (HPA) system, and cognitive functions in a double-blind, randomized, controlled trial including 44 depressed inpatients over a period of 42 days. Depressive symptomatology significantly improved in all efficacy measures, with no significant differences between tianeptine and paroxetine. There was a trend toward better response to the SSRI among women. Assessment of the HPA system showed marked hyperactivity before the beginning of treatment, which then normalized in most of the patients, without significant differences between the two antidepressants. Cognitive assessments showed no significant differences between the two drugs investigated. The results of the current study suggest that the initial effect, i.e., enhancement or decrease of 5-HT release, is only indirectly responsible for antidepressant efficacy, and they support the notion that downstream adaptations within and between nerve cells are crucial. The normalization of the HPA system as a common mode of action of different antidepressants seems to be of special interest.Keywords
This publication has 64 references indexed in Scilit:
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000
- Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic DepressionAmerican Journal of Psychiatry, 2000
- Depression-related cognitive impairment: possibilities for its pharmacological treatmentJournal of Affective Disorders, 1996
- Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and ? inhibiting fluvoxamine utilizing EEG mapping and psychometryJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- TianeptineDrugs, 1995
- Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Paroxetine in the elderly depressed patientInternational Clinical Psychopharmacology, 1994
- Spouse-Aided Therapy with AgoraphobicsThe British Journal of Psychiatry, 1992
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960